QT Prolongation Alert Responses from a 10-Month Hospital Study

A 10-month prospective study at Geneva University Hospitals evaluated clinical responses to drug-induced QT prolongation alerts. The dataset includes intervention rates for 154 patients across geriatric and orthopedic wards, focusing on ECG monitoring and treatment modifications. It was authored by Aurélien Simona and published under a CC-BY-4.0 license in May 2026.

Use Cases

• Evaluate the effectiveness of QT prolongation alerts based on intervention rates described in the study
• Analyze differences in clinical response between geriatric and orthopedic patient populations based on the ward-specific results
• Study the gap between risk identification and therapeutic changes based on the reported low rate of treatment modifications
• Assess the contribution of as-needed medications to QT risk scores as mentioned in the description

Strengths

• Includes data from 154 patients across two distinct hospital wards (geriatrics and orthopedics)
• Describes a 10-month prospective study design with clinical interventions assessed within a 7-day window
• Reports specific intervention rates ranging from 45.2% to 91.9%, depending on the ward and time window

Limitations

• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment
• Data may reflect geographic and institutional bias inherent to a single hospital study

Provenance

Source

figshare

Collection Method

Prospective study conducted in two hospital wards at Geneva University Hospitals, using a clinical decision support system (CDSS) with a pharmacodynamic risk scoring system.

Time Range

Study conducted over 10 months

Freshness

Last updated 2026-05-07 05:43:56; freshness should be verified

Geography

Geneva University Hospitals (Switzerland)